Chimeric antigen receptor T-cells for glioblastoma: The journey ahead
Chimeric antigen receptors (CARs) are genetically engineered transmembrane cell receptors consisting of an antigen-binding ectodomain fused to an activating intracellular T-cell signaling chain. Grafting CAR molecules on T-cells enables targeted killing of tumors. The gene therapy approach of modify...
Main Authors: | Sujith Kurian Joseph, Nabil M Ahmed, Meenakshi Hegde |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Glioma |
Subjects: | |
Online Access: | http://www.jglioma.com/article.asp?issn=2589-6113;year=2019;volume=2;issue=2;spage=88;epage=95;aulast=Joseph |
Similar Items
-
Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
by: Craig A. Land, et al.
Published: (2020-11-01) -
Clinical chimeric antigen receptor‐T cell therapy: a new and promising treatment modality for glioblastoma
by: Michael P Brown, et al.
Published: (2019-01-01) -
Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future
by: Long Li, et al.
Published: (2020-11-01) -
Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
by: Tahereh Soltantoyeh, et al.
Published: (2021-06-01) -
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
by: Rowa Y. Alhabbab
Published: (2020-04-01)